AFMD Affimed Therapeutics: Forvard P/S multiplikatori
Affimed tug'ma immunitetni faollashtirish orqali saratonni davolashning innovatsion usullarini ishlab chiqadi. Kutilayotgan sotuvlar nisbatidagi narx koeffitsiyenti bozor kutganlarini aks ettiradi, bunda 3.10 ushbu ko'rsatkichning joriy darajasidir. Biznes mavsumiylik yoki makroiqtisodiy pasayishlarga bog'liq emas. Biroq, naqd pul rezervlari barqaror bo'lishiga qaramay, aksiya narxi limfoma davolashidagi muvaffaqiyatlar va R&D xarajatlari darajasiga sezgir bo'lib qolmoqda.
Affimed kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Affimed|AFMD - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Affimed N.V.|AFMD - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AFMD|AFMD - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzlari Affimed|Tezkor likvidlik koeffitsiyenti affimed.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AFMD - Sof foyda|Prognoz qilingan kelajakdagi foyda Affimed|AFMD - Kapitalizatsiyaning sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati Affimed N.V.|AFMD - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori AFMD|AFMD - Eskirishdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Affimed|AFMD - So'nggi 12 oy davomida bitta aksiya uchun foyda|Choraklik EPS foyda o'sishi affimed.com|AFMD - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Affimed
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning barcha koʻrsatkichlari tahlili:Affimed Therapeutics AFMD
Affimed onkologiyaga qarshi kurashish uchun tug‘ma immun aktivatsiyasi sohasidagi innovatsiyalarni monetizatsiya qilmoqda, bunda kelajakdagi daromadlar qotil hujayralarni aktivlashtiruvchi dori vositalarining tijoratlashtirilishiga bog‘liq. 3.10 ning joriy qiymati kompaniyaning bozor kapitalizatsiyasining kutilayotgan savdolarga nisbatini aks ettiradi, bu esa kelajakdagi P/S koeffitsiyenti orqali investorlar kutganlari haqiqiy daromad o‘sish sur’atlariga nisbatan qanchalik ortiqcha ekanligini baholash imkonini beradi.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|PTGX: Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati IMVT (immunovant.com)|KNSA (Kiniksa) - Forvard P/S multiplikatori|Grifols SA - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ADPT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Celldex Corp|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX - Forvard narx/daromad multiplikatori|Vera Therapeutics - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Dianthus Therapeutics Inc|PHVS: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ABCL|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori precigen.com|Forvard P/S multiplikatori PHAR|NKTR: Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|ZBIO - Forvard narx/daromad multiplikatori|Immunome, Inc. - Forvard P/S multiplikatori|GOSS (gossamerbio.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati SEPN (Septerna, Inc.)|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|SVRA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori RIGL|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|Sotuvga nisbatan forvard narx ENGN|RAPT - Narxning prognoz qilingan daromadga nisbati|Aerovate Therapeutics Inc (JBIO) - Forvard narx/daromad multiplikatori|ACRS: Forvard P/S multiplikatori|kyvernatx.com (KYTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TLSA|CABA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori VTYX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|ELDN - Forvard narx/daromad multiplikatori|AGEN - Narxning prognoz qilingan daromadga nisbati|Climb Bio Inc. (CLYM) - Forvard narx/daromad multiplikatori|ZURA (Zura Bio Limited) - Forvard narx/daromad multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMA (Ikena Oncology, Inc.)|Forvard P/S multiplikatori STTK|EQ - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati IFRX|XFOR: Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Forvard P/S multiplikatori|INmune Bio Corporation (INMB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics (BRNS)|Forvard narx/daromad multiplikatori kezarlifesciences.com KZR|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Akari Therapeutics PLC (AKTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|QTTB (Q32 Bio Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|GOVX: Forvard P/S multiplikatori|edesabiotech.com (EDSA) - Forvard P/S multiplikatori|IBIO (iBio) - Forvard P/S multiplikatori|Carisma Tx - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|Forvard narx/daromad multiplikatori boltbio.com BOLT|Forvard P/S multiplikatori HCWB (HCW Biologics)|APVO: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AIM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ADTX|GRI: Forvard P/S multiplikatori|XORTX Corp - Sotuvga nisbatan forvard narx|HIND (Vyome Holdings Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori revbiosciences.com|Narxning prognoz qilingan daromadga nisbati Indaptus Therapeutics, Inc. (INDP)|SCNI (Scinai Immunotherapeutics Ltd) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati CalciMedica CALI|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA - Forvard P/S multiplikatori|IGMS - Forvard P/S multiplikatori|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Third Harmonic Bio Inc (THRD) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
